http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1532444-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bb5bb06c885d09842127f387419551e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate | 2003-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_667c1f6b6a593a8785cbcfb4b63ff2b4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cd1c30e1a3397956471692d3f8adadd |
| publicationDate | 2005-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1532444-A2 |
| titleOfInvention | Method for analyzing body fluids for the presence of cancer cells and corresponding analysis kits |
| abstract | The invention relates to a method for analyzing body fluids for the presence of cancer cells, to the use thereof, to corresponding analysis kits, and to the possibilities for treating cancer that arise therefrom. The method is essentially based on the determination of the manganese superoxide dismutase, thioredoxin reductase, and/or glutathione peroxidase gene expression. The use of this method enables, in particular, a reliable diagnosis and prognosis of tumors. The reduction of an elevated expression of these genes has a therapeutic result and can be used for treating cancer. |
| priorityDate | 2002-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 676.